AFTEX
Price
$12.33
Change
-$0.01 (-0.08%)
Updated
Jul 31 closing price
Net Assets
24.95B
PTRMX
Price
$22.56
Change
-$0.04 (-0.18%)
Updated
Jul 31 closing price
Net Assets
760.41M
Interact to see
Advertisement

AFTEX vs PTRMX

AFTEX vs PTRMX Comparison Chart in %
View a ticker or compare two or three
VS
AFTEX vs. PTRMX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFTEX is a Hold and PTRMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AFTEX has more cash in the bank: 25B vs. PTRMX (760M). PTRMX pays higher dividends than AFTEX: PTRMX (3.71) vs AFTEX (3.06). AFTEX was incepted earlier than PTRMX: AFTEX (47 years) vs PTRMX (14 years). PTRMX (0.73) is less costly to investors than AFTEX (0.55). PTRMX is a more actively managed with annual turnover of: 62.00 vs. AFTEX (56.00). AFTEX initial investment is less costly to investors than PTRMX (2%) vs PTRMX (2%). AFTEX has a lower initial minimum investment than PTRMX: AFTEX (250) vs PTRMX (1000). PTRMX annual gain was more profitable for investors over the last year : 6.77 vs. AFTEX (2.15). PTRMX return over 5 years is better than : -0.98 vs. AFTEX (-9.84).
AFTEXPTRMXAFTEX / PTRMX
Total Expense Ratio0.550.7375%
Annual Report Gross Expense Ratio0.550.7375%
Fund Existence47 years14 years-
Gain YTD-1.2020.886-136%
Front Load4%2%167%
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets25B760M3,289%
Annual Yield % from dividends3.063.7183%
Returns for 1 year2.156.7732%
Returns for 3 years1.8411.3716%
Returns for 5 years-9.84-0.981,004%
Returns for 10 years-4.6914.91-31%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMYPX19.640.22
+1.13%
Goldman Sachs Large Cap Value P
MCGAX8.670.04
+0.46%
Transamerica Mid Cap Growth A
RSLEX80.130.26
+0.33%
American Funds SMALLCAP World R-4
CSCCX23.400.06
+0.26%
Calvert Small-Cap C
SMVLX99.160.15
+0.15%
Smead Value Investor